Skip to content

Guided Bone Regeneration Versus Bone Block Grafting

Randomized Controlled Clinical Trial Comparing the Clinical Measures and the Radiographical Volumetric Outcomes Assessed by Cone Beam Computed Tomography of Guided Bone Regeneration Versus Bone Block Grafting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05593198
Enrollment
44
Registered
2022-10-25
Start date
2022-11-01
Completion date
2023-07-02
Last updated
2023-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophy; Bone

Keywords

Bone Regeneration

Brief summary

The purpose of this study is to analyze the volumetric gain and stability of the newly formed bone tissue comparing guided bone regeneration with block graft.

Interventions

the bone block will be used following the principles of the Khoury technique to augment the bone volume.

PROCEDUREGuided bone regeneration

the membrane and the bone granules will be used to perform the guided bone regeneration technique.

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients in need of an implant-supported rehabilitation * Patients requiring bone regeneration * Healthy patients * Full-mouth plaque score (FMPS) and full-mouth bleeding score (FMBS) ≤ 15% * Sufficient mesiodistal and interocclusal space * At least 6 months of follow-up

Exclusion criteria

* An American Society of Anesthesiologists physical status classification ≥ III * General contraindications for surgical treatment or implant placement * Untreated periodontitis * Smoking * Excessive alcohol consumption * Any drug or medication known to affect oral status and bone turnover or contraindicate surgical treatment * No residual keratinized tissue at the experimental area * Unwillingness to return for follow-up examinations

Design outcomes

Primary

MeasureTime frameDescription
Bone volume6 Months follow upthe bone volume will be analyzed with the Cone Beam Computed Tomography scan

Secondary

MeasureTime frameDescription
Periodontal parameters6 Months follow upthe periodontal parameters will be analyzed clinically with the periodontal probe and measured in millimeters. All the periodontal parameters will be combined to describe the periodontal status of the patient.
Wound healing2 weeks follow upthe wound healing will be recorded with the Early Wound Healing Score (EHS) ranging from 0 to 10 which includes the following parameters: * clinical signs of re-epithelialization: 0 points, visible distance between incision margins; 3 points, incision margins in contact; 6 points, merged incision margins. * clinical signs of haemostasis: 0 points, bleeding at the incision margins; 1 point, presence of fibrin at the incision margins; 2 points, absence of fibrin on the incision margins. * clinical signs of inflammation: 0 points, redness involving \>50% of the incision length and/or pronounced swelling; 1 point, redness involving \<50% of the incision length; 2 points, absence of redness along the incision length.
Histological analysis6 Months follow upThe histological analysis will be performed harvesting a sample during the implant placement. Bone biopsies including both native and regenerated bone will be subjected to digital scanning to analyze the characteristics of newly formed bone, the remaining grafted material, integration of grafted material with newly formed bone, soft tissue, and local inflammation. Histomorphometric analyses will be performed to measure the following parameters: bone tissue area , graft material area , soft tissue area. Bone tissue area , graft material area , soft tissue area will be expressed relative to the total area.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026